IGFBP-3 expression in human breast cancer cells is associated with enhanced BAX and Bad expression concomitant with decreased Bcl-2 and Bcl-XL and it is independent of p53 status (Butt et al., 2000). The gene discussed is IGFBP3; the disease is breast cancer.